ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0527

Role of Terminal Uridylyl Transferase 7 in TNF-α-Induced Inflammation in Rheumatoid Arthritis Synovial Fibroblasts In Vitro

Anil singh, farheen Shaikh and Salah-uddin Ahmed, Washington State University, Spokane, WA

Meeting: ACR Convergence 2021

Keywords: Fibroblasts, Synovial, Inflammation, Micro-RNA, rheumatoid arthritis, Tumor necrosis factor (TNF)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Genetics, Genomics & Proteomics Poster (0517–0533)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Terminal uridylyl transferase 7 (TUT7), also known as Zcchc6, is a zinc finger domain-containing protein responsible for terminal uridylation of miRNA, implicated in pre-miRNA maturation and mature miRNA degradation. Dysregulated microRNA (miRNA) expression in human rheumatoid arthritis synovial fibroblast (RASFs) has been observed when compared to non-diseased SFs (NLSFs). Differential expression of miRNA is found to be associated with dysregulated miRNA biogenesis and degrading enzyme activity or stoichiometric differences in the amount of these proteins inside the cells. However, the role of TUT7 remains unexplored in RASFs.

Methods: Protein levels of miRNA biogenesis and degrading enzymes were compared by Western blotting in whole cell extracts prepared from RASFs and NLSFs. RASFs were treated with TNF-α for 24 h were used to evaluate changes in gene expression of miRNA biogenesis and degrading enzymes. RNA sequencing was performed in RASFs transfected with TUT7 siRNA or negative control (NC) siRNA in presence or absence of TNF-α (20 ng/ml) using an Ion Proton™ System. Effects of the loss of TUT7 were examined by gene enrichment of differentially expressed genes (DEGs) in presence or absence of TNF-α, followed by Gene Ontology analysis to determine key pathways modulated. Culture supernatants from siRNA-transfected samples were tested by ELISA to determine cytokine or chemokine production. Statistical value of p < 0.05 was considered significant.

Results: Western blot analysis of miRNA biogenesis machinery confirmed increased expression of Ago1 and Ago2 and decreased expression of TUT7 in RASFs compared to NLSFs (N=3 p< 0.05). We assessed the effects of TUT7 ablation by siRNA on TNF-α-induced synovial inflammation in human RASFs by RNA sequencing. RNA Sequencing analysis revealed that, out of 20,814 genes in the array, 218 DEGs were statistically qualified candidates altered in the absence of TUT7. Gene ontology study of DEGs revealed significant effects of TUT7 knockdown on cellular response to starvation, protein processing in ER, skeletal system development, heart development, and spliceosomal tri-snRNP complex assembly. Validation of RNA-seq data by quantitative RT-PCR analysis of response to TNF-α during transient knockdown of TUT7 confirmed the upregulated expression of matrix metalloproteinases (MMP1, MMP3), chemokines (CXCL5, IL-8) and cytokine (IL-6) transcripts in human RASFs. In corroboration of the mRNA data, ELISA results from TUT7 siRNA-transfected RASFs supernatants showed the significant upregulation of TNF-α-induced IL-6, IL-8, CXCL5, MMP-1, and MMP-3 production (N=4; p< 0.05).

Conclusion: This study provides novel evidence showing that loss of endogenous TUT7 in RASFs may exacerbate their hyper-responsiveness to inflammatory cytokines such as TNF-α by modulating the miRNA degradation pathway.


Disclosures: A. singh, None; f. Shaikh, None; S. Ahmed, None.

To cite this abstract in AMA style:

singh A, Shaikh f, Ahmed S. Role of Terminal Uridylyl Transferase 7 in TNF-α-Induced Inflammation in Rheumatoid Arthritis Synovial Fibroblasts In Vitro [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/role-of-terminal-uridylyl-transferase-7-in-tnf-%ce%b1-induced-inflammation-in-rheumatoid-arthritis-synovial-fibroblasts-in-vitro/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/role-of-terminal-uridylyl-transferase-7-in-tnf-%ce%b1-induced-inflammation-in-rheumatoid-arthritis-synovial-fibroblasts-in-vitro/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology